## **Core Concept**
Chronic Lymphocytic Leukemia (CLL) is a type of cancer characterized by the progressive accumulation of mature, but functionally incompetent, lymphocytes in the blood, bone marrow, and lymphoid tissues. It is a disorder of the lymphoid lineage, specifically affecting B cells in most cases. CLL is often diagnosed incidentally during routine blood tests.

## **Why the Correct Answer is Right**
The correct answer, although not explicitly provided, typically relates to key characteristics of CLL, such as its cell of origin (B cells), the presence of specific surface markers (e.g., CD5 and CD23), and clinical features like lymphocytosis, lymphadenopathy, and sometimes autoimmune phenomena. CLL cells usually express **CD19**, **CD5**, and **CD23**, distinguishing it from other lymphoproliferative disorders like mantle cell lymphoma.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details on option A, a common incorrect statement might involve suggesting CLL originates from T cells, which is incorrect as most CLL cases are of B cell origin.
- **Option B:** Similarly, without specifics, another incorrect statement could be that CLL is characterized by a high level of cell turnover, which contrasts with its indolent nature and gradual accumulation of malignant cells.
- **Option C:** This option's accuracy depends on its content, but if it suggests CLL is aggressive or rapidly progressive, this would be incorrect as CLL typically follows a chronic course.
- **Option D:** Assuming this is not the correct answer, if it inaccurately describes CLL's typical immunophenotypic markers or clinical presentation, it would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that CLL is often associated with **immunoglobulin gene mutations** and specific **cytogenetic abnormalities**, such as deletions of 13q14, 11q, or 17p, which influence prognosis and treatment. CLL cells typically co-express **CD5** and **CD23**, which aids in its diagnosis.

## **Correct Answer: D.**